tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KPRX Stock Latest News

Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
RatingsClinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
26d ago
KPRX
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
PremiumRatings
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
4M ago
KPRX
Kiora Pharmaceuticals Reports Improved Financial Performance
PremiumCompany Announcements
Kiora Pharmaceuticals Reports Improved Financial Performance
4M ago
KPRX
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
5M ago
KPRX
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
5M ago
KPRX
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
PremiumCompany AnnouncementsKiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
5M ago
KPRX
Kiora Pharmaceuticals files $100M mixed securities shelf
Premium
The Fly
Kiora Pharmaceuticals files $100M mixed securities shelf
6M ago
KPRX
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
Premium
Company Announcements
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
7M ago
8K
KPRX
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
PremiumRatings
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
8M ago
KPRX
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
8M ago
KPRX
Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
PremiumRatings
Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
8M ago
KPRX
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
PremiumThe Fly
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
8M ago
KPRX
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors
PremiumCompany AnnouncementsKiora Pharmaceuticals Holds Annual Meeting, Elects Directors
10M ago
8K
KPRX
Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating
Premium
Ratings
Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating
10M ago
KPRX
Kiora Pharmaceuticals Secures Exclusive Option Agreement with Senju
Premium
Company Announcements
Kiora Pharmaceuticals Secures Exclusive Option Agreement with Senju
10M ago
8K
KPRX
Kiora Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany Announcements
Kiora Pharmaceuticals Reports Q1 2025 Financial Results
10M ago
KPRX
Kiora Pharmaceuticals: Strong Financial Position and Strategic Partnerships Propel Buy Rating
PremiumRatings
Kiora Pharmaceuticals: Strong Financial Position and Strategic Partnerships Propel Buy Rating
11M ago
KPRX
Kiora Pharmaceuticals’ KIO-104: Promising Preclinical Data and Strong Buy Rating
PremiumRatings
Kiora Pharmaceuticals’ KIO-104: Promising Preclinical Data and Strong Buy Rating
11M ago
KPRX
Kiora Pharmaceuticals, Inc. (KPRX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Kiora Pharmaceuticals, Inc. (KPRX) Q1 Earnings Cheat Sheet
11M ago
KPRX
Kiora Pharmaceuticals: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
PremiumRatingsKiora Pharmaceuticals: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
12M ago
KPRX
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
Premium
Company Announcements
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
12M ago
KPRX
Kiora Pharmaceuticals, Inc. (KPRX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Kiora Pharmaceuticals, Inc. (KPRX) Q4 Earnings Cheat Sheet
1y ago
KPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >